UNSPSC 51284106: Cefixime

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 97I1C92E55. European Medicines Agency schedules Cefixime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07395MIG. Cefixime generally arises in the molecular formula C16H15N5O7S2.

UNSPSC 51284106 Cefixime is a Commodity code for a specific antibiotic pharmaceutical product, but the recent state and local opportunities tagged under this code do not reflect cefixime procurement. Instead, the opportunities show solicitations for other pharmaceutical products — including naloxone, drug deactivation systems, doxycycline hyclate, and ciprofloxacin hydrochloride — suggesting the code may be misapplied in tagging or that state and local procurement offices are using broader pharmaceutical supply codes to capture related drug purchases. The actual work being solicited involves the supply and delivery of pharmaceutical products to state health departments and county public health entities, with quarterly or as-needed fulfillment schedules and multi-year contract terms.

Issuing bodies under this code include the Illinois Department of Public Health and Seminole County, Florida, representing state-level health agencies and county-level public health offices. Geographic activity appears concentrated in the Midwest (Illinois) and Southeast (Florida) based on recent opportunities. Representative recent solicitations include the Illinois Department of Public Health's MMCAP Infuse piggyback pharmaceutical warehouse order (Solicitation 26482DPHPREPDB53392, awarded to Chartwell Rx LLC on August 28, 2026 with a total contract value of $2,999,999.11 over 12 months plus two optional renewal years) and Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, due July 26, 2023). Both opportunities required competitive bidding with fixed-price contracts and included standard compliance requirements such as E-Verify certification and insurance coverage. No set-aside or business enterprise program preferences were noted in the available records.